BRIC Diabetes Care Devices Market was valued at USD 3.15 billion in 2023 and is expected to reach USD 7.55 billion by 2032, growing at a CAGR of 10.13% from 2024 to 2032.
The BRIC Diabetes Care Devices Market report is a comprehensive statistical analysis of diabetes incidence and prevalence in Brazil, Russia, India, and China, providing insights into disease burden by country. It features prescription trends by device type, showing the uptake of insulin pumps, CGMs, and blood glucose monitors by regions. The report also investigates device volume patterns using historical and predicted sales data to monitor market performance. It further offers healthcare spending trends by the type of payer, classifying spending under government, commercial, private, and out-of-pocket payment systems. These differentiated data-driven insights elucidate the developing environment of diabetes treatment in BRIC countries.
Drivers
Rising Diabetes Prevalence and Increasing Awareness Initiatives are driving market growth.
The BRIC nations (Brazil, Russia, India, and China) are also experiencing a rapid increase in diabetes incidence due to sedentary lifestyles, poor diets, and genetic factors. China and India together had close to 40% of the world's diabetic population in 2023, as estimated by the International Diabetes Federation (IDF. Governments and health agencies are actively initiating awareness programs and screening initiatives to encourage early diagnosis and control. For instance, India's "National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS)" focuses on improving the accessibility of diabetes care. Further, innovations in blood glucose monitoring devices, such as continuous glucose monitoring (CGM) systems, are becoming increasingly popular due to their ease of use. The increasing focus on diabetes education and preventive monitoring is a major force driving the BRIC diabetes care devices market.
Technological Advancements in Diabetes Care Devices are accelerating the market to grow.
The BRIC region is witnessing accelerating developments in diabetes care technology, resulting in the uptake of novel monitoring and insulin delivery solutions. Continuous glucose monitors (CGM) and smart insulin pens are becoming popular, providing real-time tracking of glucose levels and pain-free insulin injections. In August 2024, Medtronic obtained FDA clearance for its Simplera™ CGM, a fully disposable CGM system that removes overtape requirements, simplifying diabetes management. In the same vein, Insulet Corporation launched its Omnipod 5 Automated Insulin Delivery System for type 2 diabetes patients, furthering the trend toward automated and convenient diabetes management. With increasing investments in digital health and AI-based diabetes management platforms, patients in BRIC nations are enjoying more efficient and precise treatment options, driving market growth.
Restraint
High Cost and Limited Accessibility of Advanced Diabetes Care Devices
One of the key controls in the BRIC Diabetes Care Devices Market is the excessive price of sophisticated diabetes care devices like continuous glucose monitors (CGMs) and insulin pumps, which makes them unavailable to much of the population. Whereas urban centers in BRIC nations have access to advanced healthcare infrastructure, rural areas tend to suffer from limited availability of these devices because of few healthcare facilities and financial constraints. For instance, in India and Brazil, the majority of diabetic patients continue to use conventional blood glucose meters instead of CGMs because of costs. Moreover, poor reimbursement strategies and the absence of comprehensive healthcare coverage in some areas further limit patient access to new diabetes care solutions. Consequently, the penetration of high-end diabetes devices is still uneven, holding back overall market growth.
Opportunities
The BRIC Diabetes Care Devices Market presents a significant opportunity with the rising adoption of digital health technologies and telemedicine solutions.
As internet penetration and smartphone adoption grow in these nations, remote patient monitoring and digital diabetes management are gaining momentum. For example, India and China have seen a dramatic rise in mobile health applications that facilitate real-time glucose monitoring and teleconsultation with healthcare professionals. Governments and individual players are spending on digital health infrastructure, reducing the efficiency and accessibility of managing diabetes, particularly in rural and underserved segments. The implementation of artificial intelligence (AI) in diabetes devices is also changing the game with personalized treatment regimes, increased patient compliance, and better management of the disease as a whole. All this is a high-return opportunity for the market players to increase their size and develop cutting-edge technology-led diabetes care products.
Challenges
One of the key issues in the BRIC Diabetes Care Devices Market is the absence of a uniform regulatory framework among these countries, posing hurdles for device makers.
Each country maintains unique medical device approval procedures, and manufacturers have to cross intricate and time-consuming regulatory hurdles. For instance, whereas registration for importing medical devices is very strict in China, India has been overhauling its regulation environment such that becoming compliant is a moving target for industry players. This regulatory inconsistency slows product launches and raises the cost of compliance. Furthermore, local manufacturing requirements and changing import bans complicate market entry even further. Firms need to spend significantly on regulatory know-how and have country-specific plans in place to maintain compliance, which can discourage new entrants and retard the uptake of innovative diabetes care products in these high-growth economies.
By Product
The Insulin Delivery Devices segment dominated the BRIC diabetes care devices market with a 55.26 % market share in 2023 because of the growing number of patients suffering from insulin-dependent diabetes and the accelerating use of sophisticated insulin delivery technologies. As a high percentage of diabetes patients need insulin therapy, products such as syringes, pumps, and insulin pens have experienced extensive usage. The convenience and reliability of contemporary insulin delivery devices, including smart insulin pens and automatic insulin pumps, have boosted patient compliance and treatment results. Moreover, government initiatives in BRIC countries, especially China and India, have increased access to insulin therapy through price subsidies and reimbursement schemes. The appeal for minimally invasive and easy-to-use insulin delivery options, combined with the continued improvement in technology, has cemented the segment's leadership in 2023.
The Blood Glucose Monitoring Devices segment is expected to grow at the fastest rate in the forecast years, led by growing awareness of diabetes care, technology advancements, and the trend towards real-time glucose monitoring. Continuous glucose monitors (CGMs) and self-monitoring blood glucose (SMBG) meters are gaining popularity as they can offer real-time glucose values, lowering the risk of complications and enhancing diabetes control. The adoption of digital health technologies, including smartphone connectivity and cloud-based data tracking, is also driving demand further. Further, reducing device prices, government-sponsored diabetes screening initiatives, and the increasing preference for non-invasive monitoring solutions are likely to drive market growth. With BRIC nations continuing to focus on preventive care and early diagnosis of diabetes, blood glucose monitoring device adoption will increase in the forecast period.
By Distribution Channel
The Hospital Pharmacies segment dominated the BRIC diabetes care devices market with a 54.26% market share in 2023 because of the large number of hospital visits related to diabetes and the growth in the number of patients who are undergoing special treatment in medical facilities. The hospitals are main centers for treating, managing, and diagnosing diabetes, thereby creating a constant demand for blood glucose monitoring systems and insulin delivery devices. In addition, hospital pharmacies stock a broad selection of sophisticated diabetes care products, such as continuous glucose monitors (CGMs) and insulin pumps, that need to be set up and used under medical supervision. With robust procurement power, bulk discounts for large purchases, and insurance coverage for hospital-based diabetes care, hospital pharmacies have emerged as the distribution channel of choice for both healthcare professionals and patients, solidifying their market leadership in 2023.
The Retail Pharmacies segment is expected to witness the fastest growth in the BRIC Diabetes Care Devices Market through the forecast period, given greater accessibility, affordability, and patient willingness for easy purchase options. With the growth of retail pharmacy chains and independent pharmacies in urban and rural markets in BRIC countries, diabetes patients have greater access to care devices like blood glucose meters, test strips, insulin pens, and needles. Also, the trend of over-the-counter (OTC) availability of self-monitoring devices and pharmacist-managed diabetes management programs has increased consumer dependence on retail pharmacies. Government efforts in increasing awareness of diabetes and its early detection, as well as increased demand for affordable and easily accessible solutions for diabetes care, are also driving the exponential growth of this segment in the years to come.
By End Use
The Hospitals segment dominated the BRIC diabetes care devices market with a 41.05% market share in 2023 because of the growing hospitalization rate for diabetes and the rising incidence of diabetes complications that need intensive medical treatment. Hospitals are the main treatment facilities for patients with advanced diabetes, providing sophisticated insulin delivery systems, continuous glucose monitoring (CGM) devices, and emergency treatment for acute complications like diabetic ketoacidosis and hypoglycemia. Also, hospitals are staffed with specialized endocrinology departments offering extensive diabetes management in the form of patient education, monitoring, and individualized treatment plans. Government-sponsored healthcare programs and insurance reimbursement policies for hospitals also reinforce hospital-based diabetes care, hence making hospitals the most favored end-use segment for both diagnosis and long-term control of diabetes among BRIC countries in 2023.
Asia Pacific dominated the BRIC diabetes care devices market with a 42.16% market share in 2023 because of the high prevalence of diabetes in the region, rising healthcare spending, and effective government initiatives for diabetes control. China and India, among other countries, have among the highest diabetes rates in the world, with China alone hosting more than 140 million diabetics as of 2023. The increasing knowledge regarding diabetes management, increasing disposable income, and greater access to advanced medical devices have greatly contributed to the uptake of continuous glucose monitors (CGMs) and insulin delivery systems. Furthermore, supportive government initiatives, like China's Volume-Based Procurement (VBP) program, have reduced the costs of critical diabetes care devices. Domestic players are also increasing their footprint, promoting market competition and availability, further solidifying Asia Pacific's dominance in the BRIC Diabetes Care Devices Market.
The Middle East & Africa region is experiencing substantial growth in the BRIC diabetes care devices market with 10.56% CAGR throughout the forecast period, fueled by the growing incidence of diabetes and enhancing healthcare infrastructure. Urbanization, lifestyle changes, and an increase in obesity levels have resulted in a high growth in diabetes cases, especially in the Gulf Cooperation Council (GCC) nations. Regional governments are proactively investing in diabetes education campaigns and national screening programs to encourage early diagnosis and treatment. Moreover, heightened healthcare expenditure, broadening insurance coverage, and collusive collaborations among foreign medical device manufacturers and domestic distributors are enhancing access to sophisticated diabetes care equipment. The increasing focus on digital healthcare and telemedicine technologies in nations such as Saudi Arabia and the UAE is also driving market growth, making the Middle East & Africa a prominent emerging region.
Medtronic plc (MiniMed 780G Insulin Pump, Guardian Connect CGM System)
Abbott (FreeStyle Libre CGM System, FreeStyle Optium Neo Blood Glucose Meter)
F. Hoffmann-La Roche Ltd (Accu-Chek Guide Blood Glucose Meter, Accu-Chek Instant S Blood Glucose Monitoring System)
Bayer AG (Contour Next Blood Glucose Monitoring System, Breeze 2 Blood Glucose Meter)
LifeScan, Inc. (OneTouch Verio Flex Blood Glucose Meter, OneTouch Select Plus Simple Glucose Monitor)
B. Braun SE (Omnican Insulin Pen Needles, Omnican Syringes)
Dexcom, Inc. (Dexcom G6 CGM System, Dexcom G7 CGM System)
Insulet Corporation (Omnipod DASH Insulin Management System, Omnipod 5 Automated Insulin Delivery System)
Ypsomed Holding AG (mylife YpsoPump Insulin Pump, mylife Unio Neva Blood Glucose Monitoring System)
Sanofi (iBGStar Blood Glucose Monitoring System, AllStar Pro Insulin Pen)
Novo Nordisk A/S (NovoPen 6 Insulin Pen, NovoFine Plus Needles)
ARKRAY, Inc. (Glucocard Shine Blood Glucose Meter, Glucocard Expression Blood Glucose Monitoring System)
Valeritas Holdings, Inc. (V-Go Wearable Insulin Delivery Device, h-Patch Insulin Delivery System)
Nipro Corporation (TRUEresult Blood Glucose Meter, TRUEbalance Blood Glucose Monitoring System)
Terumo Corporation (Medisafe With Insulin Pen, FineTouch Insulin Syringes)
Ascensia Diabetes Care Holdings AG (Contour Plus One Blood Glucose Monitoring System, Contour Next One Glucose Meter)
AgaMatrix, Inc. (Jazz Wireless 2 Blood Glucose Meter, AgaMatrix WaveSense Blood Glucose Monitoring System)
Tandem Diabetes Care, Inc. (t: slim X2 Insulin Pump, t: connect Mobile App)
Senseonics Holdings, Inc. (Eversense XL CGM System, Eversense Bridge CGM System)
GlySens Incorporated (ICGM Long-term Implantable Continuous Glucose Monitor, Eclipse CGM System)
Suppliers (These suppliers provide essential components, materials, and manufacturing solutions for diabetes care devices, including insulin delivery systems, glucose monitoring devices, and diagnostic equipment.) in the BRIC Diabetes Care Devices Market
Becton, Dickinson and Company (BD)
Thermo Fisher Scientific, Inc.
Siemens Healthineers
Molex (A Koch Company)
Freudenberg Medical
Elkem Silicones
West Pharmaceutical Services, Inc.
Jabil Healthcare
Celanese Corporation
Phillips-Medisize (A Molex Company)
August 2024 – Medtronic plc, a global leader in healthcare technology, has received approval from the U.S. Food and Drug Administration (FDA) for its Simplera continuous glucose monitor (CGM). Medtronic's first fully disposable, all-in-one CGM, the device is half the size of Medtronic's prior CGMs. The product has a slim design that simplifies the insertion and wearing process, with no need for overtape.
August 2024 – Insulet Corporation, the global leader in tubeless insulin pump technology through its Omnipod brand, has received FDA clearance of the Omnipod 5 Automated Insulin Delivery System for the management of type 2 diabetes in people aged 18 years and above in the US. With this achievement, Omnipod 5 is the first and sole FDA-approved Automated Insulin Delivery (AID) system for the management of both type 1 and type 2 diabetes.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 3.15 billion |
| Market Size by 2032 | US$ 7.55 billion |
| CAGR | CAGR of 10.13% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Blood Glucose Monitoring Devices, Insulin Delivery Devices) • By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics, Online Pharmacies, Others) • By End Use (Hospitals, Diagnostic Centers, Homecare) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Medtronic plc, Abbott, F. Hoffmann-La Roche Ltd, Bayer AG, LifeScan, Inc., B. Braun SE, Dexcom, Inc., Insulet Corporation, Ypsomed Holding AG, Sanofi, Novo Nordisk A/S, ARKRAY, Inc., Valeritas Holdings, Inc., Nipro Corporation, Terumo Corporation, Ascensia Diabetes Care Holdings AG, AgaMatrix, Inc., Tandem Diabetes Care, Inc., Senseonics Holdings, Inc., GlySens Incorporated, and other players. |
Ans: The BRIC Diabetes Care Devices Market is expected to grow at a CAGR of 10.13% during 2024-2032.
Ans: The BRIC Diabetes Care Devices Market was USD 3.15 billion in 2023 and is expected to reach USD 7.55 billion by 2032.
Ans: Rising Diabetes Prevalence and Increasing Awareness Initiatives are driving market growth.
Ans: The “Insulin Delivery Devices” segment dominated the BRIC Diabetes Care Devices Market.
Ans: Asia Pacific dominated the BRIC Diabetes Care Devices Market in 2023.
Table of Contents:
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Diabetes Incidence and Prevalence (2023), by Country
5.2 Prescription Trends (2023), by Device Type and Country
5.3 Device Volume Trends (2020-2032), by Country
5.4 Healthcare Spending (2023), by Country and Payer Type
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. BRIC Diabetes Care Devices Market Segmentation, By Product
7.1 Chapter Overview
7.2 Blood Glucose Monitoring Devices
7.2.1 Blood Glucose Monitoring Devices Market Trends Analysis (2020-2032)
7.2.2 Blood Glucose Monitoring Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 Continuous Glucose Monitoring Devices
7.2.3.1 Continuous Glucose Monitoring Devices Market Trends Analysis (2020-2032)
7.2.3.2 Continuous Glucose Monitoring Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 Self-monitoring Devices
7.2.4.1 Self-monitoring Devices Market Trends Analysis (2020-2032)
7.2.4.2 Self-monitoring Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Insulin Delivery Devices
7.3.1 Insulin Delivery Devices Market Trends Analysis (2020-2032)
7.3.2 Insulin Delivery Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
8. BRIC Diabetes Care Devices Market Segmentation, By Distribution Channel
8.1 Chapter Overview
8.2 Hospital Pharmacies
8.2.1 Hospital Pharmacies Market Trends Analysis (2020-2032)
8.2.2 Hospital Pharmacies Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Retail Pharmacies
8.3.1 Retail Pharmacies Market Trends Analysis (2020-2032)
8.3.2 Retail Pharmacies Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Diabetes Clinics
8.4.1 Diabetes Clinics Market Trends Analysis (2020-2032)
8.4.2 Diabetes Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Online Pharmacies
8.5.1 Online Pharmacies Market Trends Analysis (2020-2032)
8.5.2 Online Pharmacies Market Size Estimates and Forecasts to 2032 (USD Billion)
8.6 Others
8.6.1 Others Market Trends Analysis (2020-2032)
8.6.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. BRIC Diabetes Care Devices Market Segmentation, by End User
9.1 Chapter Overview
9.2 Hospitals
9.2.1 Hospitals Market Trends Analysis (2020-2032)
9.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Diagnostic Centers
9.3.1 Diagnostic Centers Market Trends Analysis (2020-2032)
9.3.2 Diagnostic Centers Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Homecare
9.4.1 Homecare Market Trends Analysis (2020-2032)
9.4.2 Homecare Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America BRIC Diabetes Care Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.4 North America BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.2.5 North America BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.6.2 USA BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.2.6.3 USA BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.7.2 Canada BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.2.7.3 Canada BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.8.2 Mexico BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.2.8.3 Mexico BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe BRIC Diabetes Care Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.6.2 Poland BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.1.6.3 Poland BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.7.2 Romania BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.1.7.3 Romania BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.8.2 Hungary BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.1.8.3 Hungary BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.9.2 Turkey BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.1.9.3 Turkey BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe BRIC Diabetes Care Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.4 Western Europe BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.5 Western Europe BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.6.2 Germany BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.6.3 Germany BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.7.2 France BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.7.3 France BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.8.2 UK BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.8.3 UK BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.9.2 Italy BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.9.3 Italy BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.10.2 Spain BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.10.3 Spain BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.13.2 Austria BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.13.3 Austria BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific BRIC Diabetes Care Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.4 Asia Pacific BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.5 Asia Pacific BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.6.2 China BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.6.3 China BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.7.2 India BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.7.3 India BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.8.2 Japan BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.8.3 Japan BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.9.2 South Korea BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.9.3 South Korea BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.10.2 Vietnam BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.10.3 Vietnam BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.11.2 Singapore BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.11.3 Singapore BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.12.2 Australia BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.12.3 Australia BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East BRIC Diabetes Care Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.4 Middle East BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.1.5 Middle East BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.6.2 UAE BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.1.6.3 UAE BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.7.2 Egypt BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.1.7.3 Egypt BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.9.2 Qatar BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.1.9.3 Qatar BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa BRIC Diabetes Care Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.4 Africa BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.2.5 Africa BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.6.2 South Africa BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.2.6.3 South Africa BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America BRIC Diabetes Care Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.4 Latin America BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.6.5 Latin America BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.6.2 Brazil BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.6.6.3 Brazil BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.7.2 Argentina BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.6.7.3 Argentina BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.8.2 Colombia BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.6.8.3 Colombia BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America BRIC Diabetes Care Devices Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America BRIC Diabetes Care Devices Market Estimates and Forecasts, by Distribution Channel (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America BRIC Diabetes Care Devices Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11. Company Profiles
11.1 Medtronic plc
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 Abbott
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 F. Hoffmann-La Roche Ltd
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 Bayer AG
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 LifeScan, Inc.
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 B. Braun SE
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 Dexcom, Inc.
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 Insulet Corporation
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 Ypsomed Holding AG
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 Sanofi
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
BRIC Diabetes Care Devices Market Key Segments:
By Product
Blood Glucose Monitoring Devices
Self-monitoring Devices
Blood Glucose Meter
Testing Strips
Lancets
Continuous Glucose Monitoring Devices
Sensors
Transmitters
Receiver
Insulin Delivery Devices
Pens
Pumps
Syringes
Jet Injectors
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Diabetes Clinics
Online Pharmacies
Others
By End Use
Hospitals
Diagnostic Centers
Homecare
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Artificial Heart Market was valued at USD 2.87 billion in 2023 and is expected to reach USD 7.55 billion by 2032, growing at a CAGR of 11.36% over the forecast period of 2024-2032.
The CMO/CDMO Market Size was valued at USD 23.32 Billion in 2023 and is expected to reach USD 38.87 by 2032 and grow at a CAGR of 5.86% over the forecast period 2024-2032.
The Spirometer Market Size was valued at USD 1098.50 Mn in 2023 and is expected to reach USD 2738.41 Mn by 2032 and grow at a CAGR of 10.70%.
The Tumor Profiling Market size was valued at USD 10.5 Billion in 2023 and is expected to reach USD 24.8 Billion by 2032, growing at a 10.04% CAGR.
The Physical Therapy Software Market was valued at USD 1.19 billion in 2023 and is expected to reach USD 2.94 billion by 2032, growing at a CAGR of 10.47% from 2024-2032.
Fecal Calprotectin Testing Market was valued at USD 4.51 billion in 2023 and is expected to reach USD 12.23 billion by 2032, growing at a CAGR of 11.61% from 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
